RefloDx, LLC is a Utah-based R&D company founded in 2015 by a team of engineers with backgrounds in various disciplines, including electrical, computer, mechanical, chemical, and biomedical engineering. The company focuses on developing innovative diagnostic devices and methods that are non-invasive and provide clinicians with quantitative data for assessing Gastroesophageal Reflux (GER) in patients.
With close ties to the University of Utah and access to the resources and capabilities of an R1 research university, RefloDx has been able to achieve significant milestones despite operating on a limited budget. The company has established a clinical advisory board and is well embedded in the thriving med-tech innovation ecosystem of Utah's Silicone Slopes, which provides networking connections and opportunities with other successful entrepreneurs and industry experts. RefloDx is currently developing SondeFlux, a patented device that uses ultrasound to non-invasively detect and characterize GER in a home setting, aiming to disrupt the current diagnostic testing market and provide standardized objective evidence that correlates symptoms with GER.
Generated from the website